RxSight, Inc. (RXST)
6.235
-0.02
(-0.40%)
USD |
NASDAQ |
Aug 25, 12:49
RxSight Debt to Equity Ratio : 0.0402 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0402 |
| March 31, 2026 | 0.0405 |
| December 31, 2025 | 0.04 |
| September 30, 2025 | 0.0419 |
| June 30, 2025 | 0.0421 |
| March 31, 2025 | 0.0431 |
| December 31, 2024 | 0.0437 |
| September 30, 2024 | 0.0408 |
| June 30, 2024 | 0.0415 |
| March 31, 2024 | 0.0154 |
| December 31, 2023 | 0.0188 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.0206 |
| June 30, 2023 | 0.1489 |
| March 31, 2023 | 0.3077 |
| December 31, 2022 | 0.5005 |
| September 30, 2022 | 0.4724 |
| June 30, 2022 | 0.4144 |
| March 31, 2022 | 0.3646 |
| December 31, 2021 | 0.325 |
| September 30, 2021 | 0.2991 |
| June 30, 2021 | 1.124 |
| March 31, 2021 | 0.6803 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Precision Optics Corp., Inc. | 0.2129 |
| Alcon AG | 0.2454 |
| The Cooper Cos., Inc. | 0.2986 |
| UFP Technologies, Inc. | 0.2948 |
| TransMedics Group, Inc. | 1.675 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 352.70M |
| Total Liabilities (Quarterly) | 89.36M |
| Shareholders Equity (Quarterly) | 263.34M |
| Current Ratio | 4.070 |
| Net Debt Paydown Yield | 0.15% |